Medtech Companies Face Challenges And Choices When Going Public
Executive Summary
In a panel discussion at The Medtech Conference, hosted by AdvaMed, CEOs discussed the challenges, benefits and technicalities surrounding an IPO.
You may also be interested in...
‘Storm Of Change’ Could Propel Industry On Making Daily Oral Contraceptive Available OTC In US
“It’s going to be industry people like me that have to make a decision that we're going to spend the time, we're going to spend the money to work with FDA for the many years it takes generally speaking to get these things approved,” says Femasys CEO Kathy Lee-Sepsick.
Samsara Vision Advances Tiny ‘Telescope’ For Macular Degeneration As It Ponders IPO Options
The CONCERTO trial will evaluate the company’s SING IMT, an upgrade of its 12-year-old WA IMT device, in up to 100 people in the US with age-related macular degeneration.
Investor Eye: Novalis Embraces Early Investment And Enabling Technology
Novalis Biotech employs early targeted investments to produce returns, focusing on enabling technologies and risky ventures in diagnostics and digital health.